Skip to main content
Christopher Rowley, MD, Infectious Disease, Boston, MA

ChristopherFRowleyMD

Infectious Disease • Boston, MA

Assistant Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Rowley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rowley's full profile

Already have an account?

  • Office

    110 Francis Street-Suite GB
    Beth Israel Medical Center
    Boston, MA 02215
    Phone+1 617-632-7706
    Fax+1 617-632-7626

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2002 - 2005
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1997 - 2000
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2026
  • CO State Medical License
    CO State Medical License 1999 - 2003
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • From the Lab to COVID Front Lines
    From the Lab to COVID Front LinesMarch 31st, 2020
  • Message on Opioids from HIV Docs to Colleagues Is Clear: Get Training, Prescribe Buprenorphine, Save Lives
    Message on Opioids from HIV Docs to Colleagues Is Clear: Get Training, Prescribe Buprenorphine, Save LivesOctober 17th, 2018
  • Serious Heart Condition Becoming Common in Young Injection Drug Users
    Serious Heart Condition Becoming Common in Young Injection Drug UsersApril 12th, 2018

Grant Support

  • Novel Strategy For HIV Drug Resistance Monitoring In Developing Countries.National Institute Of Allergy And Infectious Diseases2011
  • Novel Monitoring Strategy And Fitness Analysis Of Transmitted HIV Drug ResistanceNational Institute Of Allergy And Infectious Diseases2010
  • Nevirapine Resistance In Women WHO Received Nevirapine For Pmtct HIVNational Institute Of Allergy And Infectious Diseases2005–2009

Dr. Christopher Rowley, Dr. Christopher Rowley, MD, Dr. C Rowley, Dr. Christopher F Rowley